{
    "nctId": "NCT02958449",
    "briefTitle": "Prospective Clinical Investigation Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu\u00ae and No Drains (Test) in Mastectomy",
    "officialTitle": "Prospective Clinical Investigation for a Randomized, Controlled, Multicenter Non-inferiority Study Comparing Standard Wound Closure Technique With Drains (Control) to Standard Wound Closure Techniques With TissuGlu\u00ae and No Drains (Test) in Mastectomy",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer, Breast",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 77,
    "primaryOutcomeMeasure": "Number of Post-Operative Clinical Interventions",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. \u2265 18 years of age;\n2. Provide signed and dated informed consent form;\n3. Willing to comply with all study procedures, schedules and be available for the follow-up evaluations for the duration of the study;\n4. Willing to follow instructions for incision care and follow guidelines related to resumption of daily activities;\n5. Agree not to schedule any additional elective surgical procedures that involve an incision until their participation in this study is complete;\n6. In good general health in the opinion of the Investigator with no conditions that would significantly impact wound healing as determined by medical history, and review of recent concomitant medications;\n7. Requiring a mastectomy (standard, modified, modified radical) with or without sentinel node biopsy;\n8. \u2264 ASA 3 - American Society of Anesthesiologists Physical Classification System\n\nExclusion Criteria:\n\n1. Pregnancy or lactation;\n2. Known medical condition that results in compromised blood supply to tissues;\n3. Known or suspected allergy or sensitivity to any test materials or reagents;\n4. Any condition known to affect wound healing, such as collagen vascular disease;\n5. Receiving antibiotic therapy for pre-existing condition or infection;\n6. Planned immediate breast reconstruction;\n7. Concurrent use of fibrin sealants or other internal wound care devices;\n8. Unable to understand questions, instructions or the informed consent presentation in the language of the investigators performing the study;\n9. Requiring a mastectomy with ALND (as determined at time of surgery);\n10. Be participating in any conflicting medical device clinical trial within 30 days of enrollment in this study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}